Concurrent Investment Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$790K Buy
11,095
+260
+2% +$17.8K 0.01% 981
2025
Q4
$641K Buy
10,835
+40
+0.4% +$2.17K 0.01% 1038
2025
Q3
$596K Sell
10,795
-10,684
-50% -$556K 0.01% 843
2025
Q2
$926K Sell
21,479
-98
-0.5% -$3.78K 0.02% 616
2025
Q1
$854K Buy
+21,577
New +$955K 0.02% 591

Other funds holding NGVT

Concurrent Investment Advisors's NGVT Position: Q1 2026 in Review

Concurrent Investment Advisors increased its Ingevity (NGVT) stake by 2.4% in Q1 2026, buying an estimated $17.8K and bringing the position to 11,095 shares worth $790K. The position accounts for 0.01% of the portfolio, ranked #981.

Concurrent Investment Advisors first reported a position in NGVT in Q1 2025 and has held it in 5 quarters since. The position peaked at $926K in Q2 2025. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Concurrent Investment Advisors held 11,095 shares of Ingevity worth $790K as of Q1 2026.
  • Concurrent Investment Advisors bought 260 Ingevity shares in Q1 2026, an estimated $17.8K.
  • Ingevity made up 0.01% of Concurrent Investment Advisors's portfolio in Q1 2026, its #981 holding.
  • Concurrent Investment Advisors first reported a position in Ingevity in Q1 2025 and has held it in 5 quarters since.
  • Concurrent Investment Advisors's Ingevity position peaked at $926K in Q2 2025.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.